Janux Therapeutics, Inc. (JANX) quarterly income statement — complete revenue, gross profit & net income history
Janux Therapeutics, Inc. (JANX) annual income statement — 7-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 9.29M | 10.27M | 3.73M | 0 | 10M | 0 | 0 | 0 | 439K | 8.9M | 1.25M | 2.46M | 2.52M | 1.06M | 2.05M | 2.85M | 1.81M | 2.37M | 1.59M | 1.62M |
| Revenue Growth % | -7.11% | - | - | - | 2177.9% | -100% | -100% | -100% | -82.56% | 741.72% | -38.87% | -13.5% | 38.83% | -55.31% | 28.89% | 76.05% | 56.43% | 390.66% | 318.16% | - |
| Cost of Goods Sold | 40.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 532K | 531K | 500K | 14.92M | 15.87M | 0 | 13.74M | 14.09M | 10.18M | 11.17M |
| COGS % of Revenue | 436.51% | - | - | - | - | - | - | - | - | - | 42.49% | 21.58% | 19.86% | 1411.92% | 774.66% | - | 757.69% | 595.6% | 640.91% | 691.15% |
| Gross Profit | -31.26M | 10.27M | 3.73M | 0 | 10M | 0 | 0 | 0 | 439K | 8.9M | 720K | 1.93M | 2.02M | -13.87M | -13.82M | 2.85M | -11.92M | -11.72M | -8.6M | -9.55M |
| Gross Margin % | -336.51% | 100% | 100% | - | 100% | - | - | - | 100% | 100% | 57.51% | 78.42% | 80.14% | -1311.92% | -674.66% | 100% | -657.69% | -495.6% | -540.91% | -591.15% |
| Gross Profit Growth % | -412.58% | - | - | - | 2177.9% | -100% | -100% | -100% | -78.23% | 164.16% | 105.21% | -32.16% | 116.92% | -18.31% | -60.76% | 129.78% | -64.54% | -175.46% | -456.31% | - |
| Operating Expenses | 40.55M | 41.96M | 37.95M | 42.4M | 45.25M | 45.12M | 34.9M | 29.02M | 36.28M | 22.72M | 20.88M | 18.07M | 17.83M | 6.88M | 6.46M | 21.11M | 6.1M | 5.54M | 4.95M | 3.94M |
| OpEx % of Revenue | 436.51% | 408.66% | 1016.5% | - | 452.51% | - | - | - | 8264.46% | 255.36% | 1667.81% | 734.13% | 708.38% | 650.99% | 315.63% | 742.04% | 336.35% | 234.25% | 311.33% | 243.63% |
| Selling, General & Admin | 9.98M | 10.96M | 11.13M | 10.85M | 10.62M | 10.45M | 9.84M | 8.22M | 17.67M | 7.82M | 6.81M | 6.36M | 6.44M | 6.88M | 6.46M | 5.68M | 6.1M | 5.54M | 4.95M | 3.94M |
| SG&A % of Revenue | 107.46% | 106.78% | 298.23% | - | 106.22% | - | - | - | 4024.37% | 87.91% | 544.01% | 258.31% | 255.78% | 650.99% | 315.63% | 199.54% | 336.35% | 234.25% | 311.33% | 243.63% |
| Research & Development | 30.57M | 30.99M | 26.81M | 31.55M | 34.63M | 34.66M | 25.05M | 20.81M | 18.61M | 14.9M | 14.07M | 12.24M | 11.89M | 14.92M | 15.87M | 15.43M | 13.74M | 14.09M | 10.18M | 11.17M |
| R&D % of Revenue | 329.05% | 301.88% | 718.27% | - | 346.29% | - | - | - | 4240.09% | 167.45% | 1123.8% | 497.4% | 472.47% | 1411.92% | 774.66% | 542.5% | 757.69% | 595.6% | 640.91% | 691.15% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -531K | -500K | -1000K | -1000K | 0 | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -31.26M | -31.69M | -34.21M | -42.4M | -35.25M | -45.12M | -34.9M | -29.02M | -35.84M | -13.82M | -20.16M | -16.14M | -15.81M | -20.75M | -20.28M | -18.27M | -18.02M | -17.26M | -13.54M | -13.49M |
| Operating Margin % | -336.51% | -308.66% | -916.5% | - | -352.51% | - | - | - | -8164.46% | -155.36% | -1610.3% | -655.71% | -628.25% | -1962.91% | -990.28% | -642.04% | -994.04% | -729.85% | -852.23% | -834.78% |
| Operating Income Growth % | 11.33% | 29.76% | 1.96% | -46.1% | 1.65% | -226.42% | -73.09% | -79.85% | -126.66% | 33.38% | 0.59% | 11.66% | 12.26% | -20.2% | -49.76% | -35.4% | -65.29% | -176.09% | -492.91% | -715.11% |
| EBITDA | -30.8M | -31.23M | -33.74M | -41.93M | -34.75M | -44.58M | -34.38M | -28.51M | -35.33M | -13.32M | -19.63M | -15.61M | -15.31M | -20.28M | -19.83M | -17.86M | -17.77M | -17.15M | -13.46M | -13.43M |
| EBITDA Margin % | -331.57% | -304.15% | -903.94% | - | -347.5% | - | - | - | -8048.29% | -149.67% | -1567.81% | -634.13% | -608.38% | -1918.35% | -968.16% | -627.87% | -980.31% | -725.29% | -847.14% | -830.82% |
| EBITDA Growth % | 11.37% | 29.95% | 1.84% | -47.08% | 1.65% | -234.76% | -75.14% | -82.69% | -130.73% | 34.33% | 1% | 12.64% | 13.84% | -18.21% | -47.3% | -33.05% | -63.41% | -174.93% | -491.69% | -715.67% |
| D&A (Non-Cash Add-back) | 458K | 463K | 469K | 468K | 501K | 541K | 519K | 512K | 510K | 506K | 532K | 531K | 500K | 471K | 453K | 403K | 249K | 108K | 81K | 64K |
| EBIT | -21.57M | -21.97M | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -16.14M | -15.81M | -20.75M | -20.28M | -18.27M | -18.02M | -17.26M | -13.54M | -13.49M |
| Net Interest Income | 9.69M | 9.72M | 9.85M | 10.46M | 10.94M | 11.26M | 11.39M | 8.81M | 7.78M | 7.86M | 5.4M | 4.38M | 4.25M | 3.24M | 2.82M | 2.2M | 1.33M | 373K | 132K | 74K |
| Interest Income | 9.69M | 9.72M | 9.85M | 10.46M | 10.94M | 11.26M | 11.39M | 8.81M | 7.78M | 7.86M | 5.4M | 4.38M | 4.25M | 3.24M | 2.82M | 2.2M | 1.33M | 373K | 132K | 74K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 9.69M | 9.72M | 9.85M | 10.46M | 10.94M | 11.26M | 11.39M | 8.81M | 7.78M | 7.86M | 5.4M | 4.38M | 4.25M | 3.24M | 2.82M | 2.2M | 1.33M | 373K | 132K | 74K |
| Pretax Income | -21.57M | -21.97M | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M |
| Pretax Margin % | -232.21% | -214.01% | -652.59% | - | -243.13% | - | - | - | -6391.57% | -66.98% | -1178.91% | -477.77% | -459.59% | -1656.39% | -852.49% | -564.67% | -920.9% | -714.08% | -843.93% | -830.2% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -21.57M | -21.97M | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M |
| Net Margin % | -232.21% | -214.01% | -652.59% | - | -243.13% | - | - | - | -6391.57% | -66.98% | -1178.91% | -477.77% | -459.59% | -1656.39% | -852.49% | -564.67% | -920.9% | -714.08% | -843.93% | -830.2% |
| Net Income Growth % | 11.28% | 35.11% | -3.63% | -58.02% | 13.35% | -468.18% | -59.27% | -71.93% | -142.56% | 65.96% | 15.46% | 26.81% | 30.71% | -3.67% | -30.19% | -19.75% | -55.08% | -172.12% | -487.13% | -710.63% |
| Net Income (Continuing) | -21.57M | -21.97M | -24.36M | -31.95M | -24.31M | -33.86M | -23.51M | -20.22M | -28.06M | -5.96M | -14.76M | -11.76M | -11.57M | -17.51M | -17.46M | -16.07M | -16.7M | -16.89M | -13.41M | -13.42M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.34 | -0.35 | -0.39 | -0.52 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.34 | -0.40 | -0.32 | -0.33 |
| EPS Growth % | 12.82% | 36.36% | -2.63% | -44.44% | 23.53% | -400% | -26.67% | -44% | -104% | 73.81% | 28.57% | 35.9% | 26.47% | -5% | -31.25% | -18.18% | -30.77% | 35.48% | -459.44% | -153.85% |
| EPS (Basic) | -0.34 | -0.35 | -0.39 | -0.52 | -0.39 | -0.55 | -0.38 | -0.36 | -0.51 | -0.11 | -0.30 | -0.25 | -0.25 | -0.42 | -0.42 | -0.39 | -0.34 | -0.40 | -0.32 | -0.33 |
| Diluted Shares Outstanding | 63.09M | 62.94M | 62.67M | 61.97M | 62.02M | 61.9M | 61.79M | 53.75M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M |
| Basic Shares Outstanding | 63.09M | 62.94M | 62.67M | 61.97M | 62.02M | 61.9M | 61.79M | 53.75M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |